{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/11024"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/11024","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Significance of sputum volume production in tuberculosis patients in Kampala, Uganda","abstract":"Background: Traditionally, the concentration of mycobacteria in the sputum has been used as a marker of severity as well as a measure of treatment response in pulmonary tuberculosis (TB), however, because of its poor sensitivity for the prediction of TB treatment outcomes (particularly in HIV co-infected patients) more effective surrogate markers are needed. Sputum volume itself has not been previously studied as a potential determinant of treatment outcome. Objectives: To assess the association between sputum volume and clinical and radiographic markers of pulmonary TB as well as treatment outcomes among a sample of patients treated for pulmonary tuberculosis at the Mulago Hospital Uganda National Tuberculosis and Leprosy Programme (NTLP) Clinic in Kampala, Uganda. Methods and Findings: Patients admitted to NTLP between July 2003 to January 2007 were enrolled into a prospective cohort study to assess treatment outcomes during and after a course of antituberculous therapy. From this cohort, a secondary analysis of 391 study participants (with a mean follow-up time of 55 months) was conducted to assess the relationship between baseline sputum volume and TB treatment outcome. Of 296 subjects with at least one spot sputum at baseline, a multivariable analysis revealed that having higher volume sputum (≥ 3 ml) at baseline was significantly associated with the presence of cavitary disease (odds ratio (OR) 2.06, 95% confidence interval (CI) 1.2-3.54) and male gender (OR 2.1, 95% CI 1.22-3.62). Among 196 participants with spot sputum specimens who had sufficient microbiologic or demographic data to make a determination regarding their TB treatment outcome, a multivariable logistic regression revealed that having higher volume sputum (≥ 3 ml) at baseline (OR 5.76, 95% CI 1.6-28.56, p = 0.03), increased duration of pre-treatment TB symptoms(≥ 12 weeks; OR 8.07, 95% (11.69-38.59, p = 0.009) and receipt of post-secondary school education (OR 21.03, 95% CI 2.49-177.55, p = 0.005) had significant associations with an unsuccessful TB treatment outcome. Conclusions: Sputum volume produced at the time of pulmonary TB diagnosis is associated with gender and cavitary disease. Of interest, there is a statistically significant increased risk for unsuccessful TB treatment outcomes among those with higher baseline sputum spot volume (≥ 3 ml) in comparison to those with lower sputum volume (<3 mL).","abstract_html":"Background: Traditionally, the concentration of mycobacteria in the sputum has been used as a marker of severity as well as a measure of treatment response in pulmonary tuberculosis (TB), however, because of its poor sensitivity for the prediction of TB treatment outcomes (particularly in HIV co-infected patients) more effective surrogate markers are needed. Sputum volume itself has not been previously studied as a potential determinant of treatment outcome. Objectives: To assess the association between sputum volume and clinical and radiographic markers of pulmonary TB as well as treatment outcomes among a sample of patients treated for pulmonary tuberculosis at the Mulago Hospital Uganda National Tuberculosis and Leprosy Programme (NTLP) Clinic in Kampala, Uganda. Methods and Findings: Patients admitted to NTLP between July 2003 to January 2007 were enrolled into a prospective cohort study to assess treatment outcomes during and after a course of antituberculous therapy. From this cohort, a secondary analysis of 391 study participants (with a mean follow-up time of 55 months) was conducted to assess the relationship between baseline sputum volume and TB treatment outcome. Of 296 subjects with at least one spot sputum at baseline, a multivariable analysis revealed that having higher volume sputum (≥ 3 ml) at baseline was significantly associated with the presence of cavitary disease (odds ratio (OR) 2.06, 95% confidence interval (CI) 1.2-3.54) and male gender (OR 2.1, 95% CI 1.22-3.62). Among 196 participants with spot sputum specimens who had sufficient microbiologic or demographic data to make a determination regarding their TB treatment outcome, a multivariable logistic regression revealed that having higher volume sputum (≥ 3 ml) at baseline (OR 5.76, 95% CI 1.6-28.56, p = 0.03), increased duration of pre-treatment TB symptoms(≥ 12 weeks; OR 8.07, 95% (11.69-38.59, p = 0.009) and receipt of post-secondary school education (OR 21.03, 95% CI 2.49-177.55, p = 0.005) had significant associations with an unsuccessful TB treatment outcome. Conclusions: Sputum volume produced at the time of pulmonary TB diagnosis is associated with gender and cavitary disease. Of interest, there is a statistically significant increased risk for unsuccessful TB treatment outcomes among those with higher baseline sputum spot volume (≥ 3 ml) in comparison to those with lower sputum volume (&lt;3 mL).","abstract_has_math":false,"creators":["Pierre, Cassandra Marie"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Epidemiology","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2013,"date_issued":"2013","date_published":"2013","updated_at":"2026-11-18T19:29:35Z","subjects":[],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/2144/11024","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/11024","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F11024","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Pierre, Cassandra Marie"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2015-04-27T14:20:27Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2015-04-27T14:20:27Z"]},{"key":"dc:date.issued","label":"Date","values":["2013"]},{"key":"dc:date.submitted","label":"Dc Date Submitted","values":["2013"]},{"key":"dc:publisher","label":"Institution","values":["Boston University"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Epidemiology"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/11024"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (M.S.)--Boston University"]},{"key":"dc:description.abstract","label":"Abstract","values":["Background: Traditionally, the concentration of mycobacteria in the sputum has been used as a marker of severity as well as a measure of treatment response in pulmonary tuberculosis (TB), however, because of its poor sensitivity for the prediction of TB treatment outcomes (particularly in HIV co-infected patients) more effective surrogate markers are needed. Sputum volume itself has not been previously studied as a potential determinant of treatment outcome. Objectives: To assess the association between sputum volume and clinical and radiographic markers of pulmonary TB as well as treatment outcomes among a sample of patients treated for pulmonary tuberculosis at the Mulago Hospital Uganda National Tuberculosis and Leprosy Programme (NTLP) Clinic in Kampala, Uganda. Methods and Findings: Patients admitted to NTLP between July 2003 to January 2007 were enrolled into a prospective cohort study to assess treatment outcomes during and after a course of antituberculous therapy. From this cohort, a secondary analysis of 391 study participants (with a mean follow-up time of 55 months) was conducted to assess the relationship between baseline sputum volume and TB treatment outcome. Of 296 subjects with at least one spot sputum at baseline, a multivariable analysis revealed that having higher volume sputum (≥ 3 ml) at baseline was significantly associated with the presence of cavitary disease (odds ratio (OR) 2.06, 95% confidence interval (CI) 1.2-3.54) and male gender (OR 2.1, 95% CI 1.22-3.62). Among 196 participants with spot sputum specimens who had sufficient microbiologic or demographic data to make a determination regarding their TB treatment outcome, a multivariable logistic regression revealed that having higher volume sputum (≥ 3 ml) at baseline (OR 5.76, 95% CI 1.6-28.56, p = 0.03), increased duration of pre-treatment TB symptoms(≥ 12 weeks; OR 8.07, 95% (11.69-38.59, p = 0.009) and receipt of post-secondary school education (OR 21.03, 95% CI 2.49-177.55, p = 0.005) had significant associations with an unsuccessful TB treatment outcome. Conclusions: Sputum volume produced at the time of pulmonary TB diagnosis is associated with gender and cavitary disease. Of interest, there is a statistically significant increased risk for unsuccessful TB treatment outcomes among those with higher baseline sputum spot volume (≥ 3 ml) in comparison to those with lower sputum volume (<3 mL)."]},{"key":"dc:title","label":"Title","values":["Significance of sputum volume production in tuberculosis patients in Kampala, Uganda"]}]}],"canonical_facts":{"dc:creator":["Pierre, Cassandra Marie"],"dc:date.accessioned":["2015-04-27T14:20:27Z"],"dc:date.available":["2015-04-27T14:20:27Z"],"dc:date.issued":["2013"],"dc:date.submitted":["2013"],"dc:description":["Thesis (M.S.)--Boston University"],"dc:description.abstract":["Background: Traditionally, the concentration of mycobacteria in the sputum has been used as a marker of severity as well as a measure of treatment response in pulmonary tuberculosis (TB), however, because of its poor sensitivity for the prediction of TB treatment outcomes (particularly in HIV co-infected patients) more effective surrogate markers are needed. Sputum volume itself has not been previously studied as a potential determinant of treatment outcome. Objectives: To assess the association between sputum volume and clinical and radiographic markers of pulmonary TB as well as treatment outcomes among a sample of patients treated for pulmonary tuberculosis at the Mulago Hospital Uganda National Tuberculosis and Leprosy Programme (NTLP) Clinic in Kampala, Uganda. Methods and Findings: Patients admitted to NTLP between July 2003 to January 2007 were enrolled into a prospective cohort study to assess treatment outcomes during and after a course of antituberculous therapy. From this cohort, a secondary analysis of 391 study participants (with a mean follow-up time of 55 months) was conducted to assess the relationship between baseline sputum volume and TB treatment outcome. Of 296 subjects with at least one spot sputum at baseline, a multivariable analysis revealed that having higher volume sputum (≥ 3 ml) at baseline was significantly associated with the presence of cavitary disease (odds ratio (OR) 2.06, 95% confidence interval (CI) 1.2-3.54) and male gender (OR 2.1, 95% CI 1.22-3.62). Among 196 participants with spot sputum specimens who had sufficient microbiologic or demographic data to make a determination regarding their TB treatment outcome, a multivariable logistic regression revealed that having higher volume sputum (≥ 3 ml) at baseline (OR 5.76, 95% CI 1.6-28.56, p = 0.03), increased duration of pre-treatment TB symptoms(≥ 12 weeks; OR 8.07, 95% (11.69-38.59, p = 0.009) and receipt of post-secondary school education (OR 21.03, 95% CI 2.49-177.55, p = 0.005) had significant associations with an unsuccessful TB treatment outcome. Conclusions: Sputum volume produced at the time of pulmonary TB diagnosis is associated with gender and cavitary disease. Of interest, there is a statistically significant increased risk for unsuccessful TB treatment outcomes among those with higher baseline sputum spot volume (≥ 3 ml) in comparison to those with lower sputum volume (<3 mL)."],"dc:identifier.uri":["https://hdl.handle.net/2144/11024"],"dc:language.iso":["en_US"],"dc:publisher":["Boston University"],"dc:title":["Significance of sputum volume production in tuberculosis patients in Kampala, Uganda"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Epidemiology"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T19:29:35Z"}